Not logged inFamily history-adjusted age recommendation for initiating breast cancer screening: 7-year follow-up from a prospective cohort study
Zhu, Juan; Wang, Le; Gong, Weiwei; Li, Xue; Wang, Youqing; Zhu, Chen; Li, Huizhang; Shi, Lei; Yang, Chen; Du, Lingbin .png)
Share.png)
SaveScreenLungNet: Personalized Long-Term Prediction of Lung Cancer Risk from a Single Low-Dose CT ScreeningLin, Chengting; Tan, Weixiong; Zhou, Zhen; Zhu, Lingying; Du, Lingbin; Zhu, Chen; Li, Yuwei; Chen, Kun; Shi, Liting; Ji, Chen; Ma, Zhengxiao; Zhou, Qian; Zhang, Liang; Yang, Jiantao; Ma, Hongxia; Zhu, Meng; Zhou, Xianglan; Wu, Lili; Wang, Enyu; Yu, Yizhou; Shi, Lei Share Save Share Save Share Save Share Save Targeting stromal cells in tumor microenvironment as a novel treatment strategy for gliomaGeng, Ziang; Zhang, Zheyuan; Wang, Miaohan; Yu, Zhongxue; Wang, Siqi; Lu, Jun; Wang, Shisong; Guan, Shu; Li, Jinna; Liu, Tiancong; Zhu, Chen Share Save Share Save Share Save Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study (Vol 10, e67642, 2024)Wang, Youqing; Zhu, Juan; Li, Huizhang; Wang, Le; Zhu, Chen; Li, Xue; Wang, Shi; Du, Lingbin Share Save Share Save Share Save Development and evaluation of a risk prediction tool for risk-adapted screening of colorectal cancer in ChinaHang, Dong; Sun, Dianjianyi; Du, Lingbin; Huang, Jianv; Li, Jiacong; Zhu, Chen; Wang, Le; He, Jingjing; Zhu, Xia; Zhu, Meng; Song, Ci; Dai, Juncheng; Yu, Canqing; Xu, Zekuan; Li, Ni; Ma, Hongxia; Jin, Guangfu; Yang, Ling; Chen, Yiping; Du, Huaidong; Cheng, Xiangdong; Chen, Zhengming; Lv, Jun; Hu, Zhibin; Li, Liming; Shen, Hongbing Share Save Diterpenoid Tanshinones Can Inhibit Lung Cancer Progression by Improving the Tumor Microenvironment and Downregulation of NF-κB Expression (vol 9, pg 7230, 2024)Xu, Hao; Guo, Ning Ning; Zhu, Chen Ying; Ye, Lin Yan; Yan, Xing Yi; Liu, Yong Qin; Zhang, Ze Yan; Hussain, Liaqat; Zhang, Guangji Share Save Share Save Share Save Colorectal cancer screening based on fecal immunochemical test and risk assessment: a population-based study including two million participants in ChinaHang, Dong; Zhu, Chen; Yang, Xiaolin; He, Jinjin; Li, Huizhang; Pan, Tingting; Wang, Le; Wang, Shi; Wu, Wei; Zhong, Jieming; Gong, Weiwei; Zhu, Meng; Song, Ci; Ma, Hongxia; Li, Ni; Qiu, Yanfei; Jin, Guangfu; Hu, Zhibin; Du, Lingbin; Cheng, Xiangdong; Shen, Hongbing Share Save Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort studyZhu, Juan; Wang, Le; Gong, Weiwei; Li, Xue; Wang, Youqing; Zhu, Chen; Li, Huizhang; Shi, Lei; Yang, Chen; Du, Lingbin Share Save Penpulimab combined with anlotinib and nab-paclitaxel plus gemcitabine (PAAG) as first-line treatment for advanced metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase II studyDu, J.; Tong, F.; Sha, H.; Sun, Y.; Zhu, Y.; Qi, L.; Li, X.; Li, W.; Yang, Y.; Li, Z.; Xu, C.; Ni, J.; Zhang, X.; Zhu, C.; Wang, X.; Qian, X.; Liu, B. Share Save Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort StudyWang, Le; Wang, Youqing; Wang, Fei; Gao, Yumeng; Fang, Zhimei; Gong, Weiwei; Li, Huizhang; Zhu, Chen; Chen, Yaoyao; Shi, Lei; Du, Lingbin; Li, Ni Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
